Background: Urokinase (uPA) and the urokinase receptor (uPAR) form a multifunctional system capable of concurrently regulating pericellular proteolysis, cell-surface adhesion, and mitogenesis. The role of uPA and uPAR in directed proteolysis is well established and its function in cellular adhesiveness has recently been clarified by numerous studies. The molecular mechanisms underlying the mitogenic effects of uPA and uPAR are still unclear, however.
Background
Abnormal accumulation of proliferating neointimal vascular smooth muscle cells (VSMCs) is a prominent feature of several vascular diseases, including atherosclerosis and restenosis [1] . Excessive VSMC proliferation can be initiated by several growth factors, including platelet-derived growth factor, fibroblast growth factor, and epidermal growth factor, all of which are released in response to arterial injury [2] [3] [4] . A growing body of evidence, however, implies that the fibrinolytic system, in particular urokinase-type plasminogen activator, might contribute significantly to vascular remodeling, most likely by affecting cellular migration and proliferation.
Urokinase (uPA) and its specific receptor (uPAR) form a multifunctional system capable of concurrently regulating pericellular proteolysis, cell-surface adhesion, and mitogenesis (for reviews see [5, 6] ). The role of uPA and uPAR in directed proteolysis is well established and its function in cellular adhesiveness has been clarified by numerous studies (see [5, 6] and references therein). The mitogenic effects of the complex remain the least well understood aspect of uPA and uPAR action, however. The data available to date confirm the mitogenic response to uPA in a wide variety of cell types. Nevertheless, the data are contradictory in terms of the underlying molecular mechanisms. It is unclear whether or not induction of cell proliferation requires the complete uPA molecule or only its amino-terminal fragment (ATF), which is catalytically inactive but still binds to the uPAR [7] [8] [9] . Furthermore, the absolute necessity of uPAR for uPA-related cell proliferation is also unclear [10] [11] [12] [13] . Finally, additional, as yet unidentified, membrane-associated proteins might be involved in uPA-induced signal transduction that culminates in cell proliferation [14] .
The possibility that the mitogenic responses related to uPA and uPAR are highly cell-specific cannot be excluded, which implies some structural specificity and underscores the diversity of underlying signaling events. Although the uPA-uPAR system is known to possess a high signaling capacity by inducing the activation of numerous pathways [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] , the requirement of this signaling for cell proliferation is still unclear. These considerations prompted us to study the molecular mechanisms whereby uPA affects cell proliferation. Here we report that in human coronary artery VSMCs, uPA induces cell proliferation through the activation of a signaling complex that contains, in addition to uPAR, two additional proteins, which were identified as nucleolin and casein kinase 2 (CK2).
Results

The uPAR complex contains nucleolin
We used affinity purification on uPA-conjugated cyanogen-bromide (CNBr)-activated Sepharose 4B to evaluate the association of uPAR with additional proteins. On the assumption that the interaction of uPAR with its natural ligand might lead to the activation of the receptor and associated proteins, and because protein phosphorylation is one of the most frequent activation events, we combined this assay with in vitro kinase reactions. Several prominent protein bands were seen after Coomassie staining, with one 100 kDa band being heavily phosphorylated (Figure 1a,b) . This band was cut out from the gel and subjected to in-gel tryptic cleavage followed by nano-electrospray mass spectrometry. Four sequenced peptides were found to be identical to sequences within human nucleolin [26] . Peptide 1, TGISDVFAK (using the single-letter amino-acid code), was identical to residues 324-332; peptide 2, EVFEDAAEIR, to residues 410-419; peptide 3, GLSEDTTEETLK, to residues 577-588; and peptide 4, GFGFVDFNSEEDAK, to residues 610-623. In western blot analysis, an anti-nucleolin monoclonal antibody specifically recognized this protein (Figure 1c) , whereas the antiuPAR antibody confirmed the affinity elution of uPAR from the Sepharose 4B matrix (Figure 1d ). To exclude the possibility that the co-isolation of uPAR and nucleolin was due to the non-specific co-purification of nucleolin as a contaminant, immunoprecipitation experiments were performed. Anti-uPAR antibody was able to specifically coprecipitate nucleolin (Figure 1e ) and vice versa: the uPAR was co-immunoprecipitated when anti-nucleolin antibody was used (Figure 1f ).
Nucleolin is co-localized with uPAR on the cell surface and the two are co-internalized
Nucleolin is an abundant nuclear phosphoprotein that shuttles between the nucleus and cytoplasm and that, in some instances, is also located on the cell surface (reviewed in [27] ). To examine the presence of nucleolin on the plasma membrane of VSMCs, we first used immunofluorescent laser scanning microscopy. Immunolabeling of non-permeabilized cells using anti-nucleolin monoclonal antibody revealed nucleolin at the cell surface ( Figure 2a ) where uPAR was recognized by anti-uPAR polyclonal antibodies (Figure 2b ). Interestingly, doublestaining of the proteins showed a pronounced co-localization pattern when the images were superimposed (Figure 2c ). To exclude the possibility that the surface staining of nucleolin on non-permeabilized cells might be due to the exposition of the cell interior, methanol-permeabilized samples were used for the control staining (Figure 2d,e) . In permeabilized cells, intensive nuclear staining of nucleolin was observed, whereas intracellular staining of uPAR, which is a membrane-attached protein, was, as expected, very weak. The staining patterns of permeabilized and non-permeabilized cells were completely different in that a punctate staining pattern typical of cellsurface proteins was seen only in non-permeabilized cells.
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Figure 1
Nucleolin and uPAR co-eluted after affinity matrix precipitation and co-immunoprecipitated with anti-uPAR and anti-nucleolin antibodies. To further characterize the membrane distribution of uPAR and nucleolin, immunoelectron microscopy was performed using the primary antibodies described above and gold-particle-coupled secondary antibodies. Preembedding double-labeling experiments were first performed to confirm the colocalization of the proteins observed with immunofluorescent staining The antibodies revealed that both the receptor and nucleolin were located on the cell surface. The two types of gold particles were simultaneously present on the plasma membrane, with high densities observed over areas rich in invaginations (Figure 3a,b) . To follow the process of protein internalization, incubation with both gold-labeled secondary antibodies was performed at room temperature after a constant labeling period with the primary antibodies at 4°C to prevent internalization. The incubation with the secondary antibodies under these conditions permitted the internalization process. The uPAR and nucleolin were internalized in large part simultaneously and were found together in vesicles of different shapes and sizes after only 10 minutes of internalization (Figure 3c -e).
Casein kinase 2 is associated with the uPAR-nucleolin complex and is activated by uPA
Nucleolin is a natural substrate for CK2, the enzyme that plays a decisive role in mitogenic signal transduction [28] . To address our hypothesis that CK2 might function as an ecto-enzyme in the uPAR-nucleolin complex, several approaches were used. First, we used uPA-conjugated Sepharose for the affinity elution of CK2 under the conditions described above for the uPAR and nucleolin copurification. The eluates were subjected to SDS-PAGE and immunoblotting with anti-CK2 monoclonal antibody. As shown in Figure 4a , CK2 was specifically eluted from this matrix; no band corresponding to CK2 was observed after elution from the control matrix. The association of CK2 with the uPAR-nucleolin complex was further demonstrated in co-immunoprecipitation experiments. Anti-uPAR and anti-nucleolin antibodies specifically coprecipitated CK2 (Figure 4b ,c), whereas the anti-CK2 antibody was able to effectively co-precipitate both uPAR and nucleolin (Figure 4d ,e).
To analyze the possible co-localization of CK2, uPAR and nucleolin on the cell surface, an immunocytochemical study was performed. Immunostaining of non-permeabilized VSMCs with the anti-CK2 monoclonal antibody revealed that CK2 localized at the cell surface ( 
Figure 3
Co-localization and co-internalization of uPAR and nucleolin visualized by immunoelectron microscopy. (a,b) Double immunolabeling with polyclonal anti-uPAR (5 nm gold particles) and monoclonal anti-nucleolin (12 nm gold particles) antibodies performed at 4°C. Labeling is seen on the plasma membrane including the microvilli (arrowheads). (c-e) The incubation with both gold-labeled secondary antibodies was performed under conditions that permitted internalization for 10 min (see Materials and methods for details). The labeling is seen on the plasma membrane, with high densities over areas rich in invaginations (arrowheads), and in cytoplasmic vacuoles (arrows). Magnification, × 112,000. Further experiments investigated whether there is a functional interrelationship between the components of the revealed complex. To test for CK2 activity and its probable regulation by uPA, an in vitro kinase assay was performed with the immunoprecipitates obtained with the anti-CK2 antibody. Cells that were activated with uPA at different time points were used. The results of these experiments demonstrated that the CK2 activity of VSMCs increased quickly and transiently in response to uPA, the activation being observed within 5-10 minutes of uPA stimulation (Figure 6a ). The increase in CK2 activity, although reliable, was minor (about a two-fold increase). This small increase might be explained by the fact that the anti-CK2 antibody precipitated the total pool of CK2 present in cell lysates, whereas only cell-surface uPAR-associated enzyme was supposedly uPA-sensitive. To prove this supposition, further immunoprecipitation experiments were performed using anti-uPAR and anti-nucleolin antibodies. The results shown in Figure 6b clearly demonstrate that the uPAR immunoprecipitates were indeed specifically enriched in the uPA-activated CK2, whereas immunoprecipitation with anti-nucleolin antibody did not allow distinction between intracellular uPA-insensitive and surface-associated uPA-inducible CK2 (Figure 6b ).
CK2 and nucleolin are involved in the uPA-induced cell proliferation
To assess the effects of CK2 activation on uPA-dependent cell proliferation, VSMC proliferation was studied using a DNA-synthesis assay. When added to growth-arrested VSMCs, uPA exhibited a dose-dependent mitogenic effect within 18 h; the half-maximal effect was observed at 50 nM uPA ( Figure 7a ). As a positive control, the DNA synthesis induced by 1% fetal calf serum (FCS) was obtained in every assay (shown in the insets). To investigate whether or not CK2 and nucleolin might contribute to the uPA-related mitogenic pathway, VSMCs were first pretreated with modulators of CK2 activity, such as heparin and a CK2-substrate peptide. Pretreatment of the cells with these agents prevented uPA-induced stimulation of DNA synthesis, whereas in the positive controls, pretreatment had no effect on the mitogenic response to FCS (Figure 7b,c) . In the next set of experiments, VSMCs were pretreated with the RGG peptide. The RGG motif was initially described as an RNA-binding motif in several proteins [29] [30] [31] . The RGG domain of nucleolin was recently demonstrated to be involved in protein-protein interaction [32] . In our experiments, the RGG peptide, at a concentration ranging from 0.3 to 3 µM, completely and specifically abolished the uPAinduced increase in DNA synthesis (Figure 7d ). Taken together, these data demonstrate that CK2 and nucleolin are involved in mitogenic response of VSMCs to uPA.
The complexes formed by uPAR, nucleolin and CK2 are not found exclusively in VSMCs
To elucidate whether or not the revealed association of uPAR, nucleolin, and CK2 was specific only for VSMCs or was of a more general nature, several cell types expressing uPAR to different extents were studied ( Figure 8a ). As a negative control, an LM-TK -cell line lacking uPAR was used. The affinity co-elution of nucleolin and CK2 with uPAR was demonstrated for all cell types used in these experiments, except the LM-TKcells (Figure 8b ). Although nucleolin and CK2 were present in the cell lysates (data not shown), no specific binding of nucleolin and CK2 to the uPA-matrix was observed when LM-TK -cells were used for affinity purification. This confirms that uPAR was critical for complex formation.
To investigate whether formation of the uPAR-CK2-nucleolin complex also has the same functional mitogenic consequences in other uPAR-expressing cell types, proliferation assays were performed as described above using uPA stimulation and cell pretreatments with the CK2 substrate peptide and the RGG peptide. The data obtained in these experiments demonstrate that specific blockage of CK2 and nucleolin led to the inhibition of uPA-induced mitogenic response, not only in VSMCs, but in all uPAR-expressing cell types tested (Figure 8c and data not shown).
Discussion
The important findings in this study are that uPA induces cell proliferation through the activation of a signaling complex that contains, in addition to uPAR, two more proteins, which we identified as nucleolin and CK2. Our data are the first to demonstrate that CK2 and nucleolin are specifically involved in the cell mitogenic response to uPA. Thus, we suggest that the interaction of uPAR with its ligand uPA leads to the activation of the ecto-protein kinase CK2. The natural substrate of CK2, nucleolin, might be phosphorylated and regulated in this way.
The uPAR is a glycosylphosphatidylinositol (GPI)-anchored receptor and is devoid of a transmembrane or cytoplasmic domain [5, 6] . Details on the transmembrane mitogenic signaling of this receptor are still unclear. Evidence implicates uPA and uPAR in the regulation of VSMC growth [7] [8] [9] [10] [11] [12] [13] [14] ; however, the specific molecular mechanisms underlying this regulation are still poorly understood. Numerous studies, aimed at elucidating uPA-induced intracellular signaling pathways leading to proliferation, have revealed a high degree of diversity in different cell types. The only known pathway of transmembrane uPAR signaling is the physical interaction of uPAR with integrins, which appears to have functional consequences [6] . Whether or not the variety of intracellular signaling pathways shown to be activated through uPAR are actually mediated by integrins remains to be proved, however. Most likely, some additional signal-eliciting interacting partners for uPAR exist. In this respect, it is of special importance to identify the still unknown cell-surface proteins associated with uPA and uPAR, that enable the transmission of mitogenic signals into the cell.
CK2 is a ubiquitous serine/threonine protein kinase implicated in cell growth, proliferation, and remodeling (for reviews see [33] [34] [35] ). Interestingly, in addition to its localization within the cytoplasm and the nucleus, CK2 is located on the cell surface and acts as an ecto-enzyme, contributing to ectophosphorylation of specific membrane protein substrates. In this fashion, CK2 modulates the functional properties of these substrates [36] . These observations imply an important physiological regulatory role for extracellular phosphorylation; however, the exact mechanisms remain unclarified.
One CK2-specific substrate is nucleolin. CK2 phosphorylates nucleolin in vitro and has been co-purified with nucleolin as a tight complex [28, 37] . Nucleolin is one of the most abundant nuclear phosphoproteins implicated in pre-ribosomal RNA transcription and ribosome biogenesis [27] . One remarkable characteristic of nucleolin is that it shuttles constantly between the nucleus and the cytoplasm [38] and thereby might act as a carrier for ribosomal proteins [32] . Moreover, recent reports provide evidence that nucleolin might also be localized on the cell surface, where it might function as a cell-surface receptor or binding protein. Cellsurface nucleolin has been reported to bind growth factors, laminin, lipoproteins, a complement inhibitor Factor J, and several viruses [39] [40] [41] [42] [43] [44] [45] . These findings raise the possibility that the interaction between nucleolin and other membrane-located proteins might represent a signaling mechanism that modifies the cellular mitogenic response.
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Figure 7
Participation of CK2 and nucleolin in mediating the mitogenic effect of uPA on VSMC.
(a) Quiescent cells were treated with increasing concentrations of uPA in serum-free medium. DNA synthesis was measured after 18 h using 5-bromo-2‚-deoxy-uridine (BrdU) labeling. Cells were pretreated with the indicated concentrations of (b) heparin, (c) CK2-substrate peptide, or (d) RGG peptide, or used without pretreatment (control). DNA synthesis was determined in the uPAstimulated (grey bars) or non-stimulated (white bars) cells. The recombinant RGG peptide was prepared as described previously [8] . As a positive control and a control for the inhibition specificity, DNA synthesis induction with 1% FCS was performed in each assay (shown in the insets). Cell specificity of uPAR, CK2 and nucleolin association. (a) Expression levels of uPAR in the indicated cell types was determined using the uPAR-ELISA Kit (Monozyme). (b) Co-elution of nucleolin, CK2 and uPAR from different cell types was performed using control and uPA-conjugated CNBr-activated Sepharose 4B and analyzed by immunoblotting as described in Figure 1 (see also the Materials and methods). (c) Cell proliferation induced by uPA and cell pretreatments with peptides were performed on human fibroblasts, as described for VSMC in Figure 7 . CASMC, coronary artery smooth muscle cells; HT1080, human fibrosarcoma cell line HT1080; HF, human skin fibroblasts; ECV, human umbilical vein endothelial cell line ECV-304; LM-TK -, uPAR-deficient LM-TK -cell line.
cell surface, where they presumably form a functional complex. CK2 and nucleolin were co-purified with uPAR on the uPA-coupled affinity matrix and were specifically coprecipitated with the anti-uPAR antibody. The cell-surface localization of CK2 and nucleolin and their co-localization with uPAR were shown by several sets of immunomicroscopy experiments. We also showed that CK2 was activated in response to uPA; this fact confirms the supposed functional interrelations between the components of the complex. Moreover, an in vitro kinase assay revealed a high phosphorylation level of nucleolin affinity isolated on the uPA-matrix, which might be due to nucleolin activation within the complex initiated by uPA-uPAR binding.
Our results also suggest a functional role for the newly identified complex, implicating the involvement of CK2 and nucleolin in the uPA-induced proliferation of VSMCs. The mitogenic response to uPA observed in our experiments is consistent with other reports demonstrating mitogenic activity of uPA in different cell types [7] [8] [9] [10] 12, 13] . It is striking that the compounds known to specifically inhibit CK2 and nucleolin completely abolished the uPArelated mitogenic effect, whereas they had no influence on the serum-induced cell proliferation. Thus, the most potent of polyanionic CK2 inhibitors, heparin, used at concentrations consistent with its IC 50 value, eliminated the increase in DNA synthesis induced by uPA. To understand whether or not the contribution of CK2 to the proliferative effect required the enzyme-substrate interaction, a CK2-substrate peptide was used as a binding competitor. These experiments documented the inhibition of the VSMC mitogenic response to uPA upon the addition of CK2 substrate in vitro in a dose-dependent manner. The results suggest that an enzyme-substrate interaction was involved. We used the recombinant RGG peptide to further show that the uPA-induced pathway leading to cell proliferation was modified when the nucleolin-binding domain responsible for protein-protein interaction was affected. These data suggest that the RGG domain of nucleolin is implicated in complex formation, whereas the amino-terminal domain, which possesses the sites of multiple phosphorylation [46] , might be responsible for the activation of nucleolin by CK2.
Interestingly, the complex was not unique to VSMCs, as it was found in other uPAR-expressing cell types, such as human fibroblasts, endothelial cells, and a tumor cell line. The presence of uPAR appears to be the governing factor for complex formation; thus, no uPA-related association of nucleolin and CK2 was observed in the LM-TK -cell line lacking uPAR. Although numerous studies suggest that both CK2 and nucleolin might be directly involved in the regulation of cell proliferation and mitotic dynamics, the mechanisms of this signaling are still unclear. Our electron microscopy studies demonstrated that nucleolin co-localizes with uPAR to the cell surface and is rapidly internalized. These findings might indicate a pathway for intracellular translocation of the activated nucleolin.
Conclusions
Several different lines of evidence have converged to link uPA and uPAR with an early signal for cell proliferation. Our findings raise the possibility that the uPA-induced mitogenic response might be realized through the formation and activation of a signaling complex comprising uPAR, nucleolin and CK2. This signaling complex appears to be of general biological importance because it was found in all uPAR-expressing cell types tested. The recognition of this pathway, coupled with our observation that heparin influences this signaling, provides clinically relevant clues to mechanisms and potential future interventions.
Materials and methods
Antibodies
Anti-uPAR polyclonal rabbit antibody (#399R) and monoclonal antibody (#3937) were purchased from American Diagnostica, Inc. Monoclonal anti-uPAR antibodies (#R-3-005) were from Monozyme, and a kind gift of N. Brünner (Finsen Laboratories, Copenhagen, Denmark), polyclonal goat anti-human uPAR antibody (#AF807) was from R+D system GmbH. Antibodies against nucleolin were from Medical & Biological Lab. Co. Monoclonal antibody to CK2α was obtained from Roche and Calbiochem-Novabiochem GmbH, the polyclonal was from CalbiochemNovabiochem GmbH. Anti-CK2 rabbit antiserum was kindly provided by O-G. Issinger (Biochemical Institute, Odense, Denmark). Alexa-488-and Alexa-546-conjugated anti-mouse and anti-rabbit IgG were provided by Molecular Probes Inc., Cy3-conjugated anti-rabbit IgG was from Jackson Immuno Research Laboratories. Secondary antibodies coupled to 5 or 12 nm colloidal gold grains were purchased from Dianova, horseradish-peroxidase-conjugated anti-mouse antibody was from Santa Cruz Biotechnology, Inc., Sigma Chemicals Co. or Pierce. Anti-rabbit horseradish-peroxidase-conjugated IgG was also from Pierce. Antibodies for control experiments were purchased from Sigma and Jackson Immuno Research Laboratories. Peroxidase-conjugated AffiniPure mouse anti goat IgG (H+L) was from Dianova.
Cell culture
Human coronary artery VSMC were obtained from Clonetics. The cells were grown in SmGM2 medium (Clonetics) supplemented with 5% FBS and used in the sixth passage. For the uPA stimulation experiments, the cells were cultured for 24 h in serum-free SmGM2 medium and were then treated with uPA and lysed as described previously [23, 25] . The human fibrosarcoma HT1080 cell line was grown in DMEM (Biochrom-Seromed) supplemented with 12% FBS, human skin fibroblasts (primary culture, passage 5-6) and human umbilical vein endothelial cell line ECV-304 were grown in growth medium M199 EARLE (Biochrom-Seromed) supplemented with 10% FBS, the LM-TK -cell line was grown in DMEM supplemented with 10% FBS.
Protein precipitation on the uPA-matrix, in vitro kinase assay, immunoprecipitation, and ELISA
For the preparation of the uPA-matrix, recombinant wild-type uPA was coupled to CNBr-activated Sepharose 4B (Pharmacia Biotech) as recommended by the manufacturer. As a control matrix, CNBr-activated Sepharose 4B uncoupled and coupled with BSA was used. Cell lysates (600-1000 µg total protein) were precleared at room temperature for 30 min with Sepharose 4B (Pharmacia Biotech), and were then precipitated for 2 h at room temperature using the uPA-Sepharose, which was previously blocked overnight with HEPES-NaCl buffer (10 mM HEPES, 150 mM NaCl pH7.4) containing 1% BSA and 0.1% Tween20. After incubation with precleared cell lysate, uPA-Sepharose was washed five times with HEPES-NaCl buffer containing 0.1% Tween20 and once with kinase buffer (25 mM HEPES pH 7.2, 5 mM MnCl 2 , 20 mM MgCl 2 , 1 mM sodium orthovanadate, 0.1% Nonidet P40). The in vitro kinase reactions were performed as described elsewhere [47] , in 100 µl kinase buffer containing 10 µCi [γ-32 P]ATP for 10 min at room temperature. Precipitates were washed subsequently twice with 200 µl kinase buffer, eluted by Laemmli buffer, and subjected to SDS-PAGE. The gels were Coomassie-stained, dried and the phosphorylated proteins were then analyzed by autoradiography. Western blot analysis of washed precipitates and immunoprecipitation were performed as described elsewhere [23, 25] . For uPAR ELISA, cells were lysed as described above and the uPAR amount in the cell lysates was measured using the uPAR ELISA Kit (#UR-5, Monozyme) as advised by the manufacturers.
Enzymatic in-gel digestion and nano-electrospray mass spectrometry
Protein bands containing highly phosphorylated proteins were recovered in the Coomassie-stained gel and were cut out. The peptide extracts were produced by in-gel tryptic cleavage of the protein [48] in cleavage buffer (100 mM Tris-HCl pH 8.0, 1 mM CaCl 2 , 10% acetonitrile) containing 0.2-0.5 µg trypsin at 37°C for 15 h. After digestion, the gel was incubated with two volumes 2% aqueous TFA at 60°C for 1 h. The techniques used for nano electrospray mass spectrometry are described in detail elsewhere [49, 50] .
Immunofluorescent and electron microscopy studies
The techniques used for immunofluorescent microscopy are described in detail elsewhere [51, 52] . The images were acquired with NORAN OZ (Noran Instruments) supported with InterVision 1.7. For electron microscopy, pre-embedding double-staining was performed. Chilled cells were incubated with a mixture of primary polyclonal anti-uPAR and monoclonal anti-nucleolin antibodies (40 µg/ml of each antibody in precooled SmGM medium) at 4°C for 1 h, then were washed twice with ice-cold HEPES-NaCl buffer, incubated with secondary antibodies conjugated with 5 nm or 12 nm gold grains at 4°C for 1 h, and washed twice again with ice-cold HEPES-NaCl buffer. For the investigation of internalization events, cells were incubated with the secondary antibodies at room temperature for 10 min. Labeled cells were immediately fixed with 1% glutaraldehyde. After 1 h of fixation at room temperature, the cells were rinsed with PBS, scraped off from the plates using a rubber policeman, transferred into Eppendorf tubes, and centrifuged. Cell pellets were then resuspended in a mixture of 20% polyvinylpyrrolidone (PVP) and 1.8 M sucrose for at least 3-4 h and then mounted as small droplets onto the specimen stubs and stored in liquid nitrogen. Ultrathin cryosections were prepared using a REICHERT Ultracut S ultramicrotome equipped with an FCS cryoattachment and transferred to 100-mesh hexagonal formvar-carbon-coated grids with PVPsucrose droplets, washed with ddH 2 O and subsequently stained and embedded in aqueous solution containing 2.8% polyvinylalcohol and 3% silicotungtic acid. The sections were observed and photographed on a Philips EM 400 transmission electron microscope.
Cell proliferation assay
Cells were grown on a 48-well plate to 60% confluence in SmGM2 and deprived overnight in SmGM medium without supplements. Cells were stimulated for 18 h with increasing concentrations of uPA in serum-free medium without or in the presence of heparin (Sigma), CK2-substrate peptide (RRREEETEEE, Alexis), and the RGG peptide; as positive control and control for the specificity of the inhibition, 1% serum were added. The DNA synthesis was measured using 5-bromo-2‚-deoxy-uridine (BrdU) labeling and detection kit III (Roche) as advised by the manufacturers.
Casein kinase-2 activity assay
For the measurements of CK2 activity, the cells were stimulated with 50 nM uPA, lysed, and subjected to immunoprecipitation as described elsewhere [23, 25] using antibodies against CK2, uPAR, or nucleolin. CK2 activity was measured in the immunoprecipitates using the Casein Kinase-2 assay kit (Upstate Biotechnology).
Statistics
Each experiment was repeated at least three times and representative figures have been shown. For microscopy studies, at least 20-40 cells from at least five separate experiments were examined under each experimental condition.
Because Current Biology operates a 'Continuous Publication System' for Research Papers, this paper has been published on the internet before being printed. The paper can be accessed from http://biomednet.com/cbiology/cub -for further information, see the explanation on the contents page.
